Globeflex Capital L P Makes New Investment in MKS Inc. $MKSI

Key Points

• Globeflex Capital initiated a $13.0 million position in MKS during the second quarter by purchasing 29,241 shares, making MKS its sixth-largest holding. Institutional investors and hedge funds collectively own 99.79% of the company.
• MKS reported stronger-than-expected quarterly results, with EPS of $3.30 versus the $2.91 consensus and revenue of $1.25 billion, up 28.3% year over year. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $385.
• The company declared a quarterly dividend of $0.25 per share, equivalent to an annualized $1.00 payout and a 0.4% yield. Meanwhile, insiders sold 37,491 shares worth approximately $12.1 million over the past three months.

Globeflex Capital L P bought a new position in shares of MKS Inc. (NASDAQ:MKSI - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 29,241 shares of the scientific and technical instruments company's stock, valued at approximately $13,006,000. MKS makes up 1.7% of Globeflex Capital L P's investment portfolio, making the stock its 6th largest position.

A number of other large investors also recently modified their holdings of the stock. Keating Financial Advisory Services Inc. acquired a new stake in shares of MKS in the second quarter valued at approximately $25,000. Global Retirement Partners LLC raised its position in MKS by 560.0% in the 4th quarter. Global Retirement Partners LLC now owns 165 shares of the scientific and technical instruments company's stock worth $26,000 after purchasing an additional 140 shares during the last quarter. IFP Advisors Inc lifted its holdings in MKS by 616.7% during the 4th quarter. IFP Advisors Inc now owns 172 shares of the scientific and technical instruments company's stock worth $27,000 after buying an additional 148 shares in the last quarter. Allied Private Wealth LLC acquired a new position in MKS during the 2nd quarter worth $33,000. Finally, Clearstead Trust LLC bought a new position in MKS in the 2nd quarter valued at $36,000. 99.79% of the stock is currently owned by institutional investors and hedge funds.

MKS Stock Performance

Shares of MKS stock opened at $279.11 on Monday. The firm has a fifty day moving average of $341.95 and a two-hundred day moving average of $294.68. The stock has a market capitalization of $18.87 billion, a price-to-earnings ratio of 44.52, a PEG ratio of 0.59 and a beta of 1.98. MKS Inc. has a 52 week low of $97.50 and a 52 week high of $447.62. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.72 and a current ratio of 1.14.

MKS (NASDAQ:MKSI - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $3.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.39. MKS had a return on equity of 24.72% and a net margin of 10.15%.The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.20 billion. During the same period last year, the company earned $1.77 EPS. The firm's revenue was up 28.3% on a year-over-year basis. MKS has set its Q3 2026 guidance at 3.270-3.890 EPS. As a group, equities research analysts predict that MKS Inc. will post 12.96 EPS for the current year.

MKS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Tuesday, August 25th will be issued a dividend of $0.25 per share. The ex-dividend date is Tuesday, August 25th. This represents a $1.00 dividend on an annualized basis and a yield of 0.4%. MKS's dividend payout ratio (DPR) is 15.95%.

Insider Activity at MKS

In related news, Director Joseph B. Donahue sold 2,100 shares of the business's stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $327.95, for a total transaction of $688,695.00. Following the completion of the transaction, the director owned 10,033 shares in the company, valued at approximately $3,290,322.35. The trade was a 17.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Michelle M. Mccarthy sold 2,434 shares of the business's stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $315.23, for a total transaction of $767,269.82. Following the transaction, the chief accounting officer owned 2 shares of the company's stock, valued at approximately $630.46. This represents a 99.92% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 37,491 shares of company stock worth $12,102,072. 0.57% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. The Goldman Sachs Group reissued a "sell" rating and issued a $265.00 target price on shares of MKS in a research note on Thursday, May 7th. BMO Capital Markets started coverage on MKS in a report on Tuesday, June 30th. They issued an "outperform" rating and a $453.00 price target on the stock. Mizuho set a $360.00 price objective on MKS in a research report on Thursday, August 6th. Citigroup boosted their price objective on MKS from $425.00 to $430.00 and gave the stock a "buy" rating in a report on Friday, August 7th. Finally, Needham & Company LLC upped their target price on shares of MKS from $360.00 to $390.00 and gave the company a "buy" rating in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, MKS currently has a consensus rating of "Moderate Buy" and a consensus price target of $385.00.

About MKS

MKS Instruments, Inc NASDAQ: MKSI designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company's core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company's product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source